United States Solid Tumor Drug Market Report 2017

December 2017 | 112 pages | ID: U6C9CAC3819EN
QYResearch

Abstracts

In this report, the United States Solid Tumor Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Solid Tumor Drug in these regions, from 2012 to 2022 (forecast).

United States Solid Tumor Drug market competition by top manufacturers/players, with Solid Tumor Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• Biogen
• Baxter
• Celgene Corporation
• Abbott Laboratories
• Pfizer Inc
• Amgen Limited & Amgen Ireland Limited
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Johnson & Johnson

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Small Molecules
• Biologics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Neurology
• Radiology
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Solid Tumor Drug Market Report 2017

1 SOLID TUMOR DRUG OVERVIEW

1.1 Product Overview and Scope of Solid Tumor Drug
1.2 Classification of Solid Tumor Drug by Product Category
  1.2.1 United States Solid Tumor Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Solid Tumor Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Small Molecules
  1.2.4 Biologics
1.3 United States Solid Tumor Drug Market by Application/End Users
  1.3.1 United States Solid Tumor Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Neurology
  1.3.4 Radiology
  1.3.5 Others
1.4 United States Solid Tumor Drug Market by Region
  1.4.1 United States Solid Tumor Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Solid Tumor Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Solid Tumor Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Solid Tumor Drug Status and Prospect (2012-2022)
  1.4.5 New England Solid Tumor Drug Status and Prospect (2012-2022)
  1.4.6 The South Solid Tumor Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Solid Tumor Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Solid Tumor Drug (2012-2022)
  1.5.1 United States Solid Tumor Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Solid Tumor Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES SOLID TUMOR DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Solid Tumor Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Solid Tumor Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Solid Tumor Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Solid Tumor Drug Market Competitive Situation and Trends
  2.4.1 United States Solid Tumor Drug Market Concentration Rate
  2.4.2 United States Solid Tumor Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Solid Tumor Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SOLID TUMOR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Solid Tumor Drug Sales and Market Share by Region (2012-2017)
3.2 United States Solid Tumor Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Solid Tumor Drug Price by Region (2012-2017)

4 UNITED STATES SOLID TUMOR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Solid Tumor Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Solid Tumor Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Solid Tumor Drug Price by Type (2012-2017)
4.4 United States Solid Tumor Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SOLID TUMOR DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Solid Tumor Drug Sales and Market Share by Application (2012-2017)
5.2 United States Solid Tumor Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SOLID TUMOR DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Solid Tumor Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biogen
  6.2.2 Solid Tumor Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biogen Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Baxter
  6.3.2 Solid Tumor Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Baxter Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celgene Corporation
  6.4.2 Solid Tumor Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
  6.5.2 Solid Tumor Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer Inc
  6.6.2 Solid Tumor Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amgen Limited & Amgen Ireland Limited
  6.7.2 Solid Tumor Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
  6.8.2 Solid Tumor Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline plc.
  6.9.2 Solid Tumor Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 F. Hoffmann-La Roche Ltd.
  6.10.2 Solid Tumor Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eli Lilly and Company
6.12 Johnson & Johnson

7 SOLID TUMOR DRUG MANUFACTURING COST ANALYSIS

7.1 Solid Tumor Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Solid Tumor Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Solid Tumor Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Solid Tumor Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SOLID TUMOR DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Solid Tumor Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Solid Tumor Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Solid Tumor Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Solid Tumor Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Solid Tumor Drug
Figure United States Solid Tumor Drug Market Size (MT) by Type (2012-2022)
Figure United States Solid Tumor Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Small Molecules Product Picture
Figure Biologics Product Picture
Figure United States Solid Tumor Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Solid Tumor Drug by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Solid Tumor Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Solid Tumor Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Solid Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Solid Tumor Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Solid Tumor Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Solid Tumor Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Solid Tumor Drug Sales Share by Players/Suppliers
Figure 2017 United States Solid Tumor Drug Sales Share by Players/Suppliers
Figure United States Solid Tumor Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Solid Tumor Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Solid Tumor Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Solid Tumor Drug Revenue Share by Players/Suppliers
Figure 2017 United States Solid Tumor Drug Revenue Share by Players/Suppliers
Table United States Market Solid Tumor Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Solid Tumor Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Solid Tumor Drug Market Share of Top 3 Players/Suppliers
Figure United States Solid Tumor Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Solid Tumor Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Solid Tumor Drug Product Category
Table United States Solid Tumor Drug Sales (MT) by Region (2012-2017)
Table United States Solid Tumor Drug Sales Share by Region (2012-2017)
Figure United States Solid Tumor Drug Sales Share by Region (2012-2017)
Figure United States Solid Tumor Drug Sales Market Share by Region in 2016
Table United States Solid Tumor Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Solid Tumor Drug Revenue Share by Region (2012-2017)
Figure United States Solid Tumor Drug Revenue Market Share by Region (2012-2017)
Figure United States Solid Tumor Drug Revenue Market Share by Region in 2016
Table United States Solid Tumor Drug Price (USD/Kg) by Region (2012-2017)
Table United States Solid Tumor Drug Sales (MT) by Type (2012-2017)
Table United States Solid Tumor Drug Sales Share by Type (2012-2017)
Figure United States Solid Tumor Drug Sales Share by Type (2012-2017)
Figure United States Solid Tumor Drug Sales Market Share by Type in 2016
Table United States Solid Tumor Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Solid Tumor Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Solid Tumor Drug by Type (2012-2017)
Figure Revenue Market Share of Solid Tumor Drug by Type in 2016
Table United States Solid Tumor Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Solid Tumor Drug Sales Growth Rate by Type (2012-2017)
Table United States Solid Tumor Drug Sales (MT) by Application (2012-2017)
Table United States Solid Tumor Drug Sales Market Share by Application (2012-2017)
Figure United States Solid Tumor Drug Sales Market Share by Application (2012-2017)
Figure United States Solid Tumor Drug Sales Market Share by Application in 2016
Table United States Solid Tumor Drug Sales Growth Rate by Application (2012-2017)
Figure United States Solid Tumor Drug Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biogen Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Biogen Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Biogen Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Baxter Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Baxter Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Baxter Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celgene Corporation Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Celgene Corporation Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Celgene Corporation Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Laboratories Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Pfizer Inc Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Basic Information List
Table Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc. Basic Information List
Table GlaxoSmithKline plc. Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc. Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Solid Tumor Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Johnson & Johnson Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumor Drug
Figure Manufacturing Process Analysis of Solid Tumor Drug
Figure Solid Tumor Drug Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumor Drug Major Players/Suppliers in 2016
Table Major Buyers of Solid Tumor Drug
Table Distributors/Traders List
Figure United States Solid Tumor Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Solid Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Solid Tumor Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Solid Tumor Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Solid Tumor Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Solid Tumor Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Solid Tumor Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Solid Tumor Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Solid Tumor Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Solid Tumor Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Solid Tumor Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Solid Tumor Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Solid Tumor Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources